NCT02805374View on ClinicalTrials.gov

A Food Effect Study to Evaluate the Pharmacokinetics of ASP1517

PHASE1CompletedINTERVENTIONAL

Enrollment

16

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2016

Conditions

Healthy Subjects

Interventions

DRUG

ASP1517

Oral

Trial Locations (1)

Unknown

Site JP00001, Tokyo

Sponsors

Lead Sponsor

Astellas Pharma Inc

Collaborators (1)

All Listed Sponsors

collaborator

FibroGen

INDUSTRY

lead

Astellas Pharma Inc

INDUSTRY

NCT02805374 - A Food Effect Study to Evaluate the Pharmacokinetics of ASP1517 | Biotech Hunter | Biotech Hunter